14-day Premium Trial Subscription Try For FreeTry Free

Luye Pharma Group Ltd. Stock Dividends Overview

2186.HK used to pay dividends biannually. Last paid amount was HK$0.0600 at Jul 24, 2020. As of today, dividend yield (TTM) is 0%.

Dividend Yield Range

The Dividend Yield Range is the range of values in which a stock’s dividend yield has fluctuated within a specified period, often a year. It represents the variation between the highest and lowest dividend yields observed during that time frame.
AI Analysis of 2186.HK
Powered by GPT-4
New!
Dividend Analysis

Key Stats

Dividend Yield (TTM) 0%
Frequency Biannually
1Y Growth 0%
Payout Ratio 0
Amount Per Share HK$0.0600
Luye Pharma Group Ltd. has not yet announced its next dividend date. Last payment date was: Jul 24, 2020.

2186 Dividend Payout History

To ensure a understanding of 2186's dividend performance, consider examining the historical payout ratios and how they align with the company's earnings. Fluctuations in payout amounts may reflect changes in the company's dividend policy or earnings stability.


# Declaration Date Ex-Date Pay Date Amount Yield
1 Mar 27, 2020 Jun 29, 2020 Jul 24, 2020 HK$0.0600 1.27%
2 Aug 28, 2019 Sep 09, 2019 Sep 30, 2019 HK$0.0670 1.20%
3 Mar 28, 2019 Jun 14, 2019 Jul 18, 2019 HK$0.0650 1.05%
4 Aug 26, 2018 Sep 06, 2018 Sep 28, 2018 HK$0.0510 0.726%
5 Jun 14, 2018 Jun 14, 2018 Jun 14, 2018 HK$0.0540 0.631%
6 Jun 13, 2018 Jun 13, 2018 Jun 13, 2018 HK$0.0540 0.623%
7 Aug 28, 2017 Oct 04, 2017 Nov 08, 2017 HK$0.0330 0.604%
8 Mar 29, 2017 Jun 15, 2017 Jul 18, 2017 HK$0.0390 0.87%
9 Aug 29, 2016 Oct 04, 2016 Nov 08, 2016 HK$0.0370 0.728%

Dividend Sustainability

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Sustainability score

Low (50.00%)

Growth potential

No dividend expected in the near future

FAQ

What factors can affect the amount of 2186.HK's dividend payments?
The amount of 2186.HK's dividends can fluctuate based on several factors, including the company's financial performance, earnings, cash flow, capital requirements, and overall market conditions. Changes in 2186.HK sector's trends, interest rate shifts, and the company's operational adjustments can also influence dividend decisions.

Can dividends from 2186.HK stock be automatically reinvested?
If 2186.HK offers a Dividend Reinvestment Plan (DRIP), shareholders may have the option to automatically reinvest dividends to purchase additional shares. Please check with your brokerage for the availability and details of such a plan. Here's an easy guide on how to buy 2186.HK stock.

How often does 2186.HK pay dividend?
Luye Pharma Group Ltd. (2186.HK) used to pay dividends biannually. The most recent payout was on Jul 24, 2020.

How much does 2186.HK pays per share?
The last recorder (Jun 29, 2020) dividend per share was HK$0.0600.

What is 2186.HK dividend growth rate?
Over the last year, Luye Pharma Group Ltd. has witnessed growth rate of 0% . Looking back over the past 3 years, this growth rate has been 0%. Furthermore, examining the past 5 years, Luye Pharma Group Ltd. has maintained an average Dividends Per Share Growth Rate of -1.59%.
Click to get the best stock tips daily for free!

About Luye Pharma Group Ltd.

Luye Pharma Group Ltd. Luye Pharma Group Ltd., an investment holding company, develops, produces, markets, and sells pharmaceutical products worldwide. The company offers Lipusu for ovarian and breast cancer; CMNa, a chemical sensitizer for cancer radiotherapy; Tiandida for ovarian or non-small cell lung cancer; Boyounuo, an injection for the treatment of various types of cancers and other solid tumors; and Xuezhikang, a lipid regulating drug for the treatment of hyper... 2186.HK Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT